Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
7(39%)
Results Posted
33%(2 trials)

Phase Distribution

Ph phase_4
1
6%
Ph not_applicable
13
72%
Ph phase_3
1
6%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution15 total trials
Phase 3Large-scale testing
1(6.7%)
Phase 4Post-market surveillance
1(6.7%)
N/ANon-phased studies
13(86.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

7

trials recruiting

Total Trials

18

all time

Status Distribution
Active(7)
Completed(6)
Terminated(1)
Other(4)

Detailed Status

Completed6
Recruiting5
unknown4
Active, not recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
7
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (6.7%)
Phase 41 (6.7%)
N/A13 (86.7%)

Trials by Status

recruiting528%
active_not_recruiting211%
unknown422%
completed633%
withdrawn16%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT05565599Not Applicable

An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

Active Not Recruiting
NCT07262255Not Applicable

WATCHMAN FLX Pro European Registry

Recruiting
NCT03616028Not Applicable

The CONFORMAL Early Feasibility Study

Active Not Recruiting
NCT02681042Not Applicable

Left Atrial Appendage Closure With SentreHeart Lariat® Device

Completed
NCT06405750Not Applicable

Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate

Recruiting
NCT05224375Not Applicable

A Trial Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

Completed
NCT06984731

The Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion.

Recruiting
NCT03243175Phase 3

Avoiding Anticoagulation After IntraCerebral Haemorrhage

Recruiting
NCT04193826Not Applicable

The Conformal Prague Study

Completed
NCT05204212Not Applicable

Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease

Recruiting
NCT04807283Not Applicable

Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System

Unknown
NCT05743322Not Applicable

The Usefulness of Biatrial 3D Printing to Plan Transseptal Puncture for the Left Atrial Appendage Closure

Unknown
NCT04376606Not Applicable

Changes of Left Atrial Function and Quality of Life After Transcatheter Closure of Left Atrial Appendage in Patients With Atrial Fibrillation

Completed
NCT02426944Phase 4

Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation

Completed
NCT03276169Not Applicable

Left Atrial Function Changes After Left Atrial Appendage Closure in Patients With Persistent Atrial Fibrillation

Completed
NCT04472871

Feasibility and Prognosis of Left Atrial Appendage Closure in Patients With Heart Failure and Atrial Fibrillation

Unknown
NCT04180605Not Applicable

Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure

Unknown
NCT03339193

Procedure RElated Outcomes With the Watchman FLX Left Atrial Appendage Closure Device

Withdrawn

All 18 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
18